Catalyst Clinical Research

Catalyst Clinical Research is a specialized clinical contract research organization (CRO) that has been acquired by Worldwide Clinical Trials. It operates through two core service models: a dedicated, full-service oncology CRO (Catalyst Oncology) and a flexible, multi-therapeutic functional service provider (Catalyst Flex). The company emphasizes a tailored, client-centric approach to support innovative biotech and biopharma companies in navigating complex clinical development. Its acquisition by Worldwide has expanded its global footprint and integrated its capabilities into a larger platform with deeper scientific and operational resources.

Integrated clinical trial service delivery model leveraging technology for study visibility, data transparency, and decision-making. Operates through two primary service lines: Catalyst Oncology (full-service CRO) and Catalyst Flex (Functional Service Provider).

Catalyst competes in the highly fragmented CRO market, positioning itself against large global full-service CROs and other niche providers. Its differentiation lies in its tailored, responsive approach for innovative biotech clients, a space now amplified by the scale and resources of its parent company, Worldwide Clinical Trials.